Representatives will vote on house bill HR 2339. The bill would prohibit the sale of flavored tobacco, flavored pipe tobacco, flavored vape e-juices, electronic cigarettes, and disposable nicotine products.
By OnLume Inc.
OnLume Inc., ("OnLume"), a medical device company developing novel imaging systems for use during surgery, announced that it had received 510(k) clearance from the U.S.
By PA Veterinary Medical Association (PAVMA)
The U.S. Food & Drug Administration (FDA) released their third update on June 27, 2019 regarding the investigation that feeding dogs "grain-free" food increases heart-related issues.
By CPC Scientific Inc.
to develop and manufacture a specific NCE for an undisclosed European biopharmaceutical partner
By CBD Training Academy
The Legal CBD Market is the biggest new opportunity of the decade. FDA meets to set guidelines for the CBD Industry, estimated at $22 billion.
A cloud-based, deep learning software platform can aid healthcare professionals in detecting over 15 types of cardiac arrhythmias using ambulatory ECG monitoring recordings.
The U.S. Food and Drug Administration (FDA) has approved a multi-regional pilot studying the use of blockchain-enabled data technology to track and verify specialty prescription drugs, to ensure safety, enhance value and improve health outcomes.
By Biostar Technology International, LLC
FDA wrongly accused the company Biostar Technology International LLC of marketing natural supplements as cancer drugs.
The Food and Drug Administration (FDA) announced that it has begun the process to make changes to its policy of releasing the names of retailers where products affected by food recalls due to outbreaks that could result in illness or deaths have been...
By My Life Among The Cannibals
On August 22, 2018, the FDA approved the use of 'magic mushrooms', just four days before the release of the new hit single 'I Ate A Mushroom' by Austin, TX based band - My Life Among The Cannibals.
Edupliance announces a webinar titled, "Effective Tools for Drafting Legally Defensible IEP's" attendees will understand how to avoid FDA and FTC warning letter. She will also discuss competitive challenges and how to handle them.
SMi Group Reports: Following the FDA's release of a Biosimilar Action Plan, this year's Biosimilars USA conference promises to explore the developments in biosimilar drug development
By Nova Biomedical
Nova Biomedical has been awarded a new multi-year group purchasing agreement for glucose meters from Premier.
By Pharmaceutical Investing News
According to our sources, Intellipharmaceutics International Inc. (IPCI) will be announcing an International partnership with a Chinese pharmaceutical company soon.
By SMi Group
SMi Group reports: Last call for registrations to Pre-Filled Syringes East Coast conference